UK markets open in 40 minutes
  • NIKKEI 225

    28,508.55
    -591.83 (-2.03%)
     
  • HANG SENG

    28,637.60
    -498.13 (-1.71%)
     
  • CRUDE OIL

    62.61
    +0.17 (+0.27%)
     
  • GOLD FUTURES

    1,786.20
    +7.80 (+0.44%)
     
  • DOW

    33,821.30
    -256.33 (-0.75%)
     
  • BTC-GBP

    39,918.34
    +199.28 (+0.50%)
     
  • CMC Crypto 200

    1,277.36
    +42.95 (+3.48%)
     
  • ^IXIC

    13,786.27
    -128.50 (-0.92%)
     
  • ^FTAS

    3,920.05
    -76.60 (-1.92%)
     

Global Single-Cell Genome Sequencing Market to Reach $3.1 Billion by 2027

ReportLinker
·27-min read

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 6. - Influencer Pool: 909. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, March 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Single-Cell Genome Sequencing Industry" - https://www.reportlinker.com/p06032884/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.



Abstract:
- Global Single-Cell Genome Sequencing Market to Reach $3.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Single-Cell Genome Sequencing estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at aCAGR of 14% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 14.4% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 13.5% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $364 Million, While China is Forecast to Grow at 13.5% CAGR
- The Single-Cell Genome Sequencing market in the U.S. is estimated at US$364 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$537.3 Million by the year 2027 trailing a CAGR of 13.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.5% and 11.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.

Select Competitors (Total 33 Featured) -

  • 10x Genomics

  • Agilent Technologies, Inc.

  • BGI

  • Bio-Rad Laboratories

  • DNA Electronics Ltd.

  • F Hoffmann-La Roche Ltd.

  • Fluidigm

  • Illumina, Inc.

  • Johnson & Johnson

  • Novogene

  • Oxford Nanopore Technologies

  • Pacific Biosciences

  • QIAGEN

  • Thermo Fisher Scientific, Inc.

  • Zephyrus Biosciences Inc.




Read the full report: https://www.reportlinker.com/p06032884/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Single-Cell Genome Sequencing Competitor Market Share Scenario
Worldwide (in %): 2020E
Global Competitor Market Shares by Segment

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Single-Cell Genome
Sequencing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 2: World Historic Review for Single-Cell Genome
Sequencing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 3: World 15-Year Perspective for Single-Cell Genome
Sequencing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Reagents by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Reagents by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 10: World Current & Future Analysis for Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 11: World Historic Review for Clinics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Clinics by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 13: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Academic &
Research Labs by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 17: World Historic Review for Academic & Research Labs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Academic & Research
Labs by Geographic Region - Percentage Breakdown of Value Sales
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Biotech &
Biopharma Companies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Biotech & Biopharma
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 21: World 15-Year Perspective for Biotech & Biopharma
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for NGS by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for NGS by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for NGS by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 25: World Current & Future Analysis for PCR by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for PCR by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for PCR by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 28: World Current & Future Analysis for qPCR by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 29: World Historic Review for qPCR by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for qPCR by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 31: World Current & Future Analysis for Microarray by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 32: World Historic Review for Microarray by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Microarray by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for MDA by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 35: World Historic Review for MDA by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for MDA by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
Market Analytics
Table 37: USA Current & Future Analysis for Single-Cell Genome
Sequencing by Product - Instruments and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 38: USA Historic Review for Single-Cell Genome Sequencing
by Product - Instruments and Reagents Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 39: USA 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 41: USA Historic Review for Single-Cell Genome Sequencing
by End-Use - Clinics, Other End-Uses, Academic & Research Labs
and Biotech & Biopharma Companies Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 42: USA 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2020 & 2027

Table 43: USA Current & Future Analysis for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 44: USA Historic Review for Single-Cell Genome Sequencing
by Technology - NGS, PCR, qPCR, Microarray and MDA Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 45: USA 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012,
2020 & 2027

CANADA
Table 46: Canada Current & Future Analysis for Single-Cell
Genome Sequencing by Product - Instruments and Reagents -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for Single-Cell
Genome Sequencing by End-Use - Clinics, Other End-Uses,
Academic & Research Labs and Biotech & Biopharma Companies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: Canada Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2020 & 2027

Table 52: Canada Current & Future Analysis for Single-Cell
Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray
and MDA - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 53: Canada Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 54: Canada 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 &
2027

JAPAN
Table 55: Japan Current & Future Analysis for Single-Cell
Genome Sequencing by Product - Instruments and Reagents -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2020 & 2027

Table 58: Japan Current & Future Analysis for Single-Cell
Genome Sequencing by End-Use - Clinics, Other End-Uses,
Academic & Research Labs and Biotech & Biopharma Companies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: Japan Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2020 & 2027

Table 61: Japan Current & Future Analysis for Single-Cell
Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray
and MDA - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 62: Japan Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 63: Japan 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 &
2027

CHINA
Table 64: China Current & Future Analysis for Single-Cell
Genome Sequencing by Product - Instruments and Reagents -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2020 & 2027

Table 67: China Current & Future Analysis for Single-Cell
Genome Sequencing by End-Use - Clinics, Other End-Uses,
Academic & Research Labs and Biotech & Biopharma Companies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: China Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2020 & 2027

Table 70: China Current & Future Analysis for Single-Cell
Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray
and MDA - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 71: China Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 72: China 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012,
2020 & 2027

EUROPE
Market Facts & Figures
Market Analytics
Table 73: Europe Current & Future Analysis for Single-Cell
Genome Sequencing by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 74: Europe Historic Review for Single-Cell Genome
Sequencing by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Single-Cell Genome
Sequencing by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Single-Cell
Genome Sequencing by Product - Instruments and Reagents -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for Single-Cell
Genome Sequencing by End-Use - Clinics, Other End-Uses,
Academic & Research Labs and Biotech & Biopharma Companies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 80: Europe Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2020 & 2027

Table 82: Europe Current & Future Analysis for Single-Cell
Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray
and MDA - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 83: Europe Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 84: Europe 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 &
2027

FRANCE
Table 85: France Current & Future Analysis for Single-Cell
Genome Sequencing by Product - Instruments and Reagents -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2020 & 2027

Table 88: France Current & Future Analysis for Single-Cell
Genome Sequencing by End-Use - Clinics, Other End-Uses,
Academic & Research Labs and Biotech & Biopharma Companies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 89: France Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 90: France 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2020 & 2027

Table 91: France Current & Future Analysis for Single-Cell
Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray
and MDA - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 92: France Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 93: France 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 &
2027

GERMANY
Table 94: Germany Current & Future Analysis for Single-Cell
Genome Sequencing by Product - Instruments and Reagents -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2020 & 2027

Table 97: Germany Current & Future Analysis for Single-Cell
Genome Sequencing by End-Use - Clinics, Other End-Uses,
Academic & Research Labs and Biotech & Biopharma Companies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: Germany Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 99: Germany 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2020 & 2027

Table 100: Germany Current & Future Analysis for Single-Cell
Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray
and MDA - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 101: Germany Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 102: Germany 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 &
2027

ITALY
Table 103: Italy Current & Future Analysis for Single-Cell
Genome Sequencing by Product - Instruments and Reagents -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 104: Italy Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 105: Italy 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2020 & 2027

Table 106: Italy Current & Future Analysis for Single-Cell
Genome Sequencing by End-Use - Clinics, Other End-Uses,
Academic & Research Labs and Biotech & Biopharma Companies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: Italy Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 108: Italy 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2020 & 2027

Table 109: Italy Current & Future Analysis for Single-Cell
Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray
and MDA - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 110: Italy Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 111: Italy 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 &
2027

UNITED KINGDOM
Table 112: UK Current & Future Analysis for Single-Cell Genome
Sequencing by Product - Instruments and Reagents - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 113: UK Historic Review for Single-Cell Genome Sequencing
by Product - Instruments and Reagents Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 114: UK 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2020 & 2027

Table 115: UK Current & Future Analysis for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 116: UK Historic Review for Single-Cell Genome Sequencing
by End-Use - Clinics, Other End-Uses, Academic & Research Labs
and Biotech & Biopharma Companies Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 117: UK 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2020 & 2027

Table 118: UK Current & Future Analysis for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 119: UK Historic Review for Single-Cell Genome Sequencing
by Technology - NGS, PCR, qPCR, Microarray and MDA Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 120: UK 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 &
2027

REST OF EUROPE
Table 121: Rest of Europe Current & Future Analysis for
Single-Cell Genome Sequencing by Product - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 122: Rest of Europe Historic Review for Single-Cell
Genome Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 123: Rest of Europe 15-Year Perspective for Single-Cell
Genome Sequencing by Product - Percentage Breakdown of Value
Sales for Instruments and Reagents for the Years 2012, 2020 &
2027

Table 124: Rest of Europe Current & Future Analysis for
Single-Cell Genome Sequencing by End-Use - Clinics, Other
End-Uses, Academic & Research Labs and Biotech & Biopharma
Companies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 125: Rest of Europe Historic Review for Single-Cell
Genome Sequencing by End-Use - Clinics, Other End-Uses,
Academic & Research Labs and Biotech & Biopharma Companies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 126: Rest of Europe 15-Year Perspective for Single-Cell
Genome Sequencing by End-Use - Percentage Breakdown of Value
Sales for Clinics, Other End-Uses, Academic & Research Labs and
Biotech & Biopharma Companies for the Years 2012, 2020 & 2027

Table 127: Rest of Europe Current & Future Analysis for
Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR,
Microarray and MDA - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 128: Rest of Europe Historic Review for Single-Cell
Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray
and MDA Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 129: Rest of Europe 15-Year Perspective for Single-Cell
Genome Sequencing by Technology - Percentage Breakdown of Value
Sales for NGS, PCR, qPCR, Microarray and MDA for the Years
2012, 2020 & 2027

ASIA-PACIFIC
Table 130: Asia-Pacific Current & Future Analysis for
Single-Cell Genome Sequencing by Product - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 131: Asia-Pacific Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 132: Asia-Pacific 15-Year Perspective for Single-Cell
Genome Sequencing by Product - Percentage Breakdown of Value
Sales for Instruments and Reagents for the Years 2012, 2020 &
2027

Table 133: Asia-Pacific Current & Future Analysis for
Single-Cell Genome Sequencing by End-Use - Clinics, Other
End-Uses, Academic & Research Labs and Biotech & Biopharma
Companies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 134: Asia-Pacific Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 135: Asia-Pacific 15-Year Perspective for Single-Cell
Genome Sequencing by End-Use - Percentage Breakdown of Value
Sales for Clinics, Other End-Uses, Academic & Research Labs and
Biotech & Biopharma Companies for the Years 2012, 2020 & 2027

Table 136: Asia-Pacific Current & Future Analysis for

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032884/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001